Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast gel for prevention of acute radiation dermatitis
IRCT20211029052907N2Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in acute radiodermatitis (ARD), sponsored by Zanjan University of Medical Sciences. Started Mar 2022; status: completed.
02
Drugs
montelukast
03
Conditions
acute radiodermatitis (ARD)
Beyond the preview
Go deeper on IRCT20211029052907N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211029052907N2.